Endoscopic submucosal dissection of esophageal granular cell tumor by Wei Lu et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Lu et al. World Journal of Surgical Oncology 2014, 12:221
http://www.wjso.com/content/12/1/221RESEARCH Open AccessEndoscopic submucosal dissection of esophageal
granular cell tumor
Wei Lu1, Mei-Dong Xu2*, Ping-Hong Zhou2, Yi-Qun Zhang2, Wei-Feng Chen2, Yun-Shi Zhong2 and Li-Qing Yao2Abstract
Background: Esophageal granular cell tumor (GCT) is a rare benign tumor with malignant potential. With wide
application of endoscopic techniques, the esophageal GCT discovery rate and treatment strategy has changed. This
study was to preliminarily evaluate outcomes of endoscopic diagnosis and treatment for esophageal GCT.
Methods: Fourteen patients (eight men, six women; median age, 48.5 years) with esophageal GCT diagnosed and
treated by esophageal endoscopy. Esophagoscopy, endoscopic ultrasound (EUS), and endoscopic submucosal
dissection (ESD) techniques were employed in diagnosis and resection.
Results: Esophageal GCTs are tumors which arise from the submucosal layer, and vary in color but with a yellowish
color on endoscopy being most common. On EUS, features were homogenous (ten cases) or mildly heterogeneous
(four cases) hypoechoic solid pattern originating from the muscularis mucosa (six cases) or submucosal layer (eight
cases) of the esophageal wall. Tumors ranged from 4 to 26 mm (mean 12.1 mm). ESD was performed in all patients
without complication. Clinical diagnosis was confirmed by pathology and immunohistochemical examination
(positive for S-100 and vimentin). The en bloc resection rate was 92.9% (13/14) pathologically. Operation time was
25 to 60 minutes, mean 38.2 ± 10.1 minutes. No recurrence was observed during a mean follow-up of 16.6 ± 12.7
(range, 4 to 40) months.
Conclusions: Esophagoscopy and EUS increased the esophageal GCT discovery rate, and its features were
summarized. Minimally invasive ESD is feasible and safe for excisional biopsy, providing pathological diagnosis
and treatment.
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Abrikossoff tumorBackground
Esophageal granular cell tumor (GCT) is a submucosal
tumor (SMT) probably originating from the Schwann cell.
It mainly affects the submucosal layer, and less commonly
the mucosal layer and muscularis propria [1]. Despite
the low morbidity, esophageal GCT is one of the most fre-
quently seen esophageal stromal tumors, second only to
leiomyoma [2]. Patients with esophageal GCTs are usually
asymptomatic; and the lesions are usually discovered
incidentally during esophagogastroduodenoscopy (EGD).
Fine-needle aspiration cytology under endoscopic ultra-
sound (EUS) guidance can be used to obtain tissue from
these subepithelial tumors, but the small specimens obtained* Correspondence: xu.meidong@zs-hospital.sh.cn
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unless otherwise stated.by needle aspiration are generally too small to make a def-
inite histopathological diagnosis.
It has been suggested that asymptomatic esophageal
GCTs smaller than 10 mm could be followed up with
periodic endoscopy and/or EUS [3]. Although esophageal
GCTs are usually benign lesions, malignant transform-
ation has been reported even in those smaller than 10 mm
[4,5]. Moreover, some patients became distressed and
desperately sought efficacious resection during follow-up
time. The traditional treatment, surgical resection, is inva-
sive and caused significant trauma [6]. Several less invasive
endoscopic approaches to remove SMTs are currently avail-
able including diathermy loop, endoscopic band ligation,
and endoscopic mucosal resection (EMR); [7-9] but they
often lead to serious complications, such as incomplete
resection or perforation. The new emerging endoscopicThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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now an option for these patients. The aim of our study
was to evaluate the endoscopic features for the diagno-




We reviewed the Zhongshan Hospital endoscopic therapy
database. A total of 14 patients with confirmed histo-
logical diagnosis of esophageal GCTs had endoscopic
diagnosis and ESD resection at our institute from 2006
to 2011. Patient medical records were reviewed for demo-
graphic data including age, gender, and indications for en-
doscopy. We obtained institutional review board approval
for the study. Informed consent for all procedures, includ-
ing gastroscopy, EUS, and ESD was obtained from each
patient.
Inclusion and exclusion criteria
Patient age from 18 to 75; esophageal submucosal lesion
found by endoscopy with size evaluated as less than 30 mm
and the patient willing to be treated by ESD technique.
Patients with any abnormality in blood clotting, bio-
chemistry or blood cell count were excluded. Patients
with esophageal venous varication disease, esophageal
stricture disease or history of esophageal surgery were
also excluded.
Endoscopic diagnosis and treatment protocol
Endoscopic and EUS reports and images were reviewed
for tumor size, appearance, location, and therapy.
EUS was performed before treatment with a high-
frequency miniprobe (UM-2R, 12 MHz; UM-3R, 20 MHz,
Olympus Optical Co, Ltd., Tokyo, Japan) to evaluate the
tumor origin and size. All available EUS images were
reviewed blindly by one proficient endoscopist.
A transparent cap (D-201-11802, Olympus, Olympus
Optical Co, Ltd., Tokyo, Japan and for all Olympus
products cited below) was attached to the front of the
endoscope. Additional equipment and accessories in-
cluded a high-frequency generator (ICC-200, ERBE,
Tübingen, Germany), argon plasma coagulation (APC)
unit (APC300, ERBE, Tübingen, Germany), injection
needle (NM-4 L-1, Olympus), hook knife (KD-620LR,
Olympus), insulated-tip knife (KD-611 L, IT2, Olympus),
hot biopsy forceps (FD-410LR, Olympus), and hemostatic
clip (HX-600-135, Olympus). An insufflator (Olympus)
was used for carbon dioxide gas insufflation during the
procedure. A mixed solution of saline with indigo carmine
(0.5%) and epinephrine (0.0005%) was prepared for sub-
mucosal injection.
Patients were treated under general anesthesia. The re-
section border was marked using argon plasma coagulationof the normal mucosa approximately 5 mm from the
tumor margin. Submucosal injection of the mixed saline
solution (5 to 10 ml) was then performed to lift the le-
sion. After sufficient lifting of the submucosal layer and
mucosa, the hook-knife was used to cut open the mucosa
in a circumferential incision around the lesion outside the
marking dots and then extend into the submucosal layer.
The circumferential incision around the lesion was made
as deep as the muscularis propria if necessary and dissec-
tion was then performed under direct vision to achieve
complete en bloc resection. The tumor was dissected out-
side the capsule, and the mixed saline solution was
injected repeatedly during the dissection when necessary.
Larger vessels or arteries with high bleeding risk were co-
agulated using hemostatic forceps. The resultant artificial
ulcer was managed routinely with APC to prevent delayed
bleeding, and hemoclips were used to close the deeply dis-
sected areas when necessary. The time from the marking
dots to complete resection of the tumor was recorded.
Histopathological evaluation
Routine H&E staining and additional immunohistochem-
istry (IHC) were performed and observed under an optical
microscope for evaluation and differential diagnosis. IHC
examination included smooth muscle actin, muscle-specific
actin, desmin, CD34, S-100, vimentin, CD117, neuron-
specific enolase, CD68, and Ki-67. Complete resection
was defined as a resected specimen with tumor-free
lateral and vertical margins. Incomplete resection was
defined as a specimen with histologically positive margins.
Outcome measurement and follow-up
Esophagogastric endoscopy was performed three and six
months after ESD, and then yearly thereafter. Endoscopic
forceps biopsies of the operation site were not routinely
performed except as necessary when suspicious lesions
were observed, and then, additional EUS examination was
performed to further diagnose suspected recurrence.
Statistical analysis
The median of continuous variables was used to present
data. The difference in tumor origin on EUS, esophageal
location, and time required for resection were compared
between the small tumor (≤10 mm in maximal diameter)
and large tumor (>10 mm in maximal diameter) groups
using a nonparametric two-independent-samples test. A
P-value less than 0.05 was taken to indicate significant
difference. Statistical analysis was performed using the
SPSS statistical analysis program (SPSS Inc., Chicago, IL,
USA).
Results
A total of 14 patients aged 29 to 75 years with GCTs of
the esophagus were identified including 8 men and 6
Table 1 Patient clinical data
Patient Age Sex Symptom Esophagus site (cm) Size (mm) EUS deptha EUS echob
1 47 Male Retrosternal discomfort, regurgitation 30 5 mm Homogenous
2 35 Female Dysphagia 23 10 sm Heterogeneous
3 45 Male Epigastric discomfort 40 6 sm Homogenous
4 53 Male Retrosternal discomfort, regurgitation 38 7 mm Homogenous
5 75 Female Regurgitation, belching 37 6 mm Heterogeneous
6 29 Male Epigastric discomfort 40 15 sm Homogenous
7 55 Female None 19 8 mm Homogenous
8 50 Female Regurgitation, belching 35 4 mm Homogenous
9 59 Female Epigastric discomfort 20 23 sm Heterogeneous
10 32 Female None 30 6 sm Homogenous
11 51 Male Retrosternal discomfort, regurgitation 35 18 sm Homogenous
12 58 Male Epigastric discomfort 37 26 sm Heterogeneous
13 48 Male Dysphagia 25 15 mm Homogenous
14 42 Male Epigastric discomfort 35 20 sm Homogenous
amm, tumor originated from the muscularis mucosa layer; sm, tumor originated from the submucosal layer.
bAll were hypoechoic, four were mildly heterogeneous, eight were homogeneous.
EUS, endoscopic ultrasound.
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Table 2. The median age at time of diagnosis was 48.5 years.
Five patients suffered epigastric discomfort; three had
retrosternal discomfort and regurgitation; two suffered re-
gurgitation and belching; two suffered from dysphagia,
and the remaining two non-symptomatic patients were
discovered by routine physical examination and gastric
endoscopy. All patients had a single esophageal GCT.









1 25 No data Negative 40
2 30 sm Negative 36
3 40 sm Negative 30
4 30 No data Negative 30
5 35 mm Negative 18
6 45 sm Negative 18
7 40 mm Negative 18
8 30 mm Negative 12
9 45 sm Positive 6
10 25 sm Negative 6
11 35 sm Negative 6
12 60 No data Unrecognized
eschar
5
13 45 No data Negative 4
14 50 sm Negative 4
mm, muscularis mucosa; sm, submucosa.esophagus, three in the proximal part, and three in the
mid-thoracic esophagus.
The endoscopic appearance of esophageal GCTs showed
variation in size, location, and coating layer of mucosa in
our study. All GCTs were described as well circumscribed
raised lesions under the mucosal layer. Eight cases were
small tumors, most of which (five cases) exhibited a small
yellowish peanut-like half protrusion under the smooth
overlying mucosa (Figure 1a). However, the larger tumors
(>10 mm) appeared as a submucosal knurl with a small
tuberculum (one case, Figure 1b) or smooth edge (five
cases). Among them, four cases had a yellowish or pale
color. Among all GCTs, three cases were covered with a
rough mucosal layer due to mucosal inflammatory disease
of the esophagus and were of a similar color to the sur-
rounding mucosa. One case showed the same color as the
mucosa without inflammatory changes.
EUS was performed in all patients who were diagnosed
with SMT in our institute. On EUS, esophageal GCT in
our study appeared as a homogenous (ten cases) or mildly
heterogeneous (four cases) hypoechoic solid pattern ori-
ginating from the muscularis mucosa (six cases) or sub-
mucosal layer (eight cases) of the esophageal wall, with
smooth edges despite the small tubercular aspect on en-
doscopy (Figure 1c). The maximum diameter of these le-
sions ranged from 4 to 26 mm with a median size of
12.1 mm. The tumors from the submucosal layer (8 cases,
mean 15.5 ± 7.6 mm) were significantly smaller than those
from the muscularis mucosa layer (6 cases, mean 34.2 ±
7.4 mm), but there was no obvious difference in size
according to the location of the lesions (Table 3).
Figure 1 Endoscopic and endoscopic ultrasound (EUS) image of different esophageal granular cell tumors (GCTs). (a) Small yellowish
peanut-like half protrusion under the smooth overlying mucosa. (b) A submucosal knurl with a small tuberculum. (c) EUS view of esophageal
GCT (mildly heterogeneous solid pattern originating from the muscularis mucosa layer).
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in our institute when the lesion was recognized as a sub-
mucosal mass, because of the high risk of destroying the
tumor integrity and causing bleeding. However, three tu-
mors mimicked mucosal lesions because of their rough
overlying mucosa, and thus endoscopic forceps biopsies
were performed. Histological diagnosis of GCT was con-
firmed via biopsy in only one of these.
Standardized ESD procedures were performed in all
patients in our study. The wound surface of the esopha-
geal GCT during ESD procedure is shown in Figure 2a
to c and the excised specimen is showed in Figure 2d.
The procedure time was from 25 to 60 minutes (mean
38.2 ± 10.1 minutes). As shown in Table 4, it took signifi-
cantly more time (P < 0.05) to remove the large tumors
(6 cases, mean 46.7 ± 8.2 minutes) than the small tumors
(8 cases, mean 31.9 ± 5.9 minutes). The procedure time
for the tumors in the submucosal layer (8 cases, mean
41.3 ± 11.3 minutes) was more than for tumors in the
muscularis mucosa layer (6 cases, mean 34.2 ± 7.4 mi-
nutes), but this was not statistically significant. Severe
complications of ESD including perforation and delayed
bleeding were not observed in all patients. The length of
hospital stay was two to four days for each patient.
Pathological diagnosis was confirmed in all cases after
ESD (Figure 3a). All the lesions were well-circumscribed
but without an obvious capsule. The margins were nega-
tive in 13/14 cases (complete resection rate 92.9%). One
case with an unrecognized eschar in the vertical margins
was designated treatment Rx (Resection margin unclear)Table 3 Comparison of tumor size according to the location a
Classification
Location in the esophagus Distal part (>32 cm)
Proximal part (≤32 cm)
Depth of the tumor origin Submucosal layer
Muscularis mucosa layer
Total
aSize detected by the endoscopic ultrasound (EUS).margin. The pathological diagnosis was supported by IHC
with the characteristic positive for S-100 and vimentin
(positive in all esophageal GCTs in our study, Figure 3b
and c).
The total follow-up time varied from 4 to 40 (mean
16.6 ± 12.7) months. No recurrent disease was observed
during follow-up, including the Rx margin case, within
18 months. A small protuberance of the mucosal scar
was found at the operation site in two cases (negative
margin) on follow-up examination. Endoscopic forceps
biopsy and EUS examination were performed. EUS did
not find any deep lesions below the mucosa and the
pathologic diagnosis from the forceps biopsy proved that
these were inflammatory granulomas.Discussion
Esophageal GCT is a type of SMT which is thought to
arise from Schwann cells of the submucosal neuronal
plexus and is usually a benign neoplasm but has some
malignant potential. Approximately 2 to 4% of esopha-
geal GCTs reported in the literature were malignant
[10], of which approximately 15% were less than 10 mm
in diameter. SMTs may more often be discovered in the
esophagus today with the advent of screening gastros-
copy. Esophageal GCTs do not exhibit specific features
on endoscopy and EUS, and it is difficult to distinguish
GCTs from other SMTs, such as leiomyoma or gastro-
intestinal stromal tumors. Thus histopathological evalu-
ation is necessary for differential diagnosis.nd origin of the tumor
Number Sizea (mean ± deviation) mm P-value
8 12.8 ± 8.1 0.699
6 11.2 ± 6.8
8 15.5 ± 7.6 0.027
6 34.2 ± 7.4
14 12.1 ± 7.3
Figure 2 Endoscopic submucosal dissection (ESD) procedure for esophageal granular cell tumor (GCT). (a) Submucosal injection of mixed
saline solution. (b) Circle labels the edge of the GCT. (c) The surface of the wound (muscularis propria layer). (d) The specimen fixed
and measured.
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opsy were employed in an attempt to obtain tissue diagno-
sis, but the results were not reliable because the tumors
were small, underlying the mucosa layer, and biopsy tissue
was not adequate. Moreover, there is sampling error when
the biopsied tissue does not encompass the areas of ma-
lignant change [11]. Complete resection of the lesion is
necessary for its accurate characterization and patient
treatment.
Open surgery or thoracoscopy is highly invasive and
can lead to a decrease in patient quality of life compared
to simple endoscopic resection. However, finding these
lesions operatively was difficult because they were less
than 20 mm in diameter. Endoscopic resection methods
can prevent skin scars caused by incisions, reduce the
inflammatory response and perceived pain associatedTable 4 Comparison of the mean operation time by tumor siz
Classification Num
Size Small tumor (≤10 mm) 8
Large tumor (>10 mm) 6
Location in the esophagus Distal part (>32 cm) 8
Proximal part (≤32 cm) 6
Depth of the tumor origin Submucosal layer 8
Muscularis mucosa layer 6
Total 14with surgical trauma, and lower the risk of postoperative
infection. Endoscopic methods are extremely minimally
invasive, and are becoming the preferred treatment of
benign esophageal tumors including leiomyoma, GCT,
and gastrointestinal stromal tumor (GIST).
Currently, traditional polypectomy and EMR are most
commonly employed for GCTs. However, complete histo-
logical resection may not always be easy to achieve using
EMR because most esophageal GCTs are not confined to
the mucosa, but rather, involve the submucosa, which re-
sults in frequent involvement of the resection margin.
To date, there are several reports showing successful
removal of esophageal GCT by EMR, but most of these
are small series or single case reports. The maximum
number of cases of successful removal of esophageal
GCT was ten from twenty-three patients reported frome, location, and depth
ber Time cost (mean ±deviation) minutes P-value
31.9 ± 5.9 0.005
46.7 ± 8.2
40.6 ± 10.5 0.316
35.0 ± 9.5
41.3 ± 11.3 0.181
34.2 ± 7.4
38.2 ± 10.1
Figure 3 Histopathological evaluation of the esophageal granular cell tumor (GCT) (×100). (a) The H&E stain of esophageal GCT.
(b) Immunohistochemistry (IHC) positive for S-100. (c) IHC positive for vimentin.
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scopic resection of these lesions, especially for lesions
exceeding 10 mm in diameter. There is a high risk of in-
complete removal. An attempt to remove a 13-mm
esophageal GCT by EMR was unsuccessful in a report
from Mayo Clinic [12].
ESD is a method of endoscopic resection that involves
circumferential cutting of the mucosa surrounding the
tumor followed by dissection of the submucosa beneath
the lesion. ESD has the advantage of a high probability
of en bloc excision and histologically complete resection
even in large lesions because the technique involves dis-
section of the submucosal tissue beneath the lesion [13].
It has been widely accepted for the treatment of early
gastric cancer and also used in resection of submucosal
tumors. ESD of GCT can provide a definite tissue diagno-
sis, and a high likelihood of complete removal of the le-
sion. In contrast to conventional EMR, ESD was able to
increase the rates of en bloc and histologically complete
resection, which may reduce local recurrent rate. In our
study, the pathological en bloc resection rate was 92.9%
(13/14). Only one was not recognizable because the cut
edge had an eschar.
We demonstrated that ESD is a safe, effective, and
minimally invasive procedure for treating esophageal
GCT. Our experience with ESD in 14 esophageal GCTs
validates the safety and efficacy in lesions less than
26 mm in size. Given the apparently low risk of this
method, it is reasonable to consider ESD the treatment
of choice for esophageal GCT.
Bleeding and perforation are the two main complica-
tions of ESD of esophageal lesions. Other complications
including pneumothorax and subcutaneous emphysema
are secondary to perforation. In this study, none of the
above complications were observed. Our measures in re-
ducing the complications of ESD were: a) keep the oper-
ation field clear and perform all the actions under direct
vision, b) prophylactic hemostasis of visualized vessels,
c) well selected length and angle of the knife during the
operation, and d) after the lesion was removed, hot biopsy
forceps coagulation or APC were performed on the whole
wound surface. This management strategy can reducedelayed hemorrhage and obliterate the residual lesion
if it exists.
The ESD procedure time in this study varied from 25
to 60 minutes, and there was a significant difference in
operation time according to tumor size. It took more time
to dissect the large tumors and tumors derived from the
submucosal layer. The length of hospital stay was two to
four days for post-operative observation. The ESD proced-
ure caused little trauma and was relatively inexpensive.
Follow-up ranged from 4 to 40 months (mean duration
16.6 ± 12.7), during which time local recurrence was not
observed in any patient at gastroscopy. However, because
of the limited number of patients and relatively short
follow-up duration, we realize that much longer follow-up
may be needed to evaluate long-term results of ESD of
esophageal GCT.
Conclusions
In summary, this study showed that esophageal GCTs
did not appear uniform under endoscopy. EUS is an ac-
curate imaging test for detecting the component of the
esophageal wall from which the mass arises. Resection by
ESD safely and entirely removed tumors without compli-
cations and should be the preferred procedure; this also
helps to obtain an exact pathological diagnosis. Further in-
vestigation is required to assess the long-term outcomes
of this method.
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